Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 24, 2020 11:00 ET | Source: 22nd Century Group, Inc

22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article

WILLIAMSVILLE, N.Y., Nov. 24, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very...
November 18, 2020 10:00 ET | Source: 22nd Century Group, Inc

22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference

WILLIAMSVILLE, N.Y., Nov. 18, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very...
November 16, 2020 09:45 ET | Source: 22nd Century Group, Inc

22nd Century Group to Present at the Virtual Fall Investor Summit on November 17

WILLIAMSVILLE, N.Y., Nov. 16, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, biotechnology company that is focused on tobacco harm reduction, very...
November 05, 2020 07:00 ET | Source: 22nd Century Group, Inc

22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020

Key Highlights: 22nd Century remains focused on its primary mission of reducing the harm caused by smoking. To this end, in recent weeks the Company has intensified its proactive efforts to...
October 22, 2020 10:00 ET | Source: 22nd Century Group, Inc

22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A

WILLIAMSVILLE, N.Y., Oct. 22, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, life science company driven by next generation biotechnology, will host...
October 19, 2020 10:00 ET | Source: 22nd Century Group, Inc

22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy Conference

WILLIAMSVILLE, N.Y., Oct. 19, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII), a leading plant-based, life science company driven by next generation biotechnology, announced...
October 14, 2020 13:00 ET | Source: 22nd Century Group, Inc

22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco Plants

WILLIAMSVILLE, N.Y., Oct. 14, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven by next...
September 24, 2020 16:05 ET | Source: 22nd Century Group, Inc

22nd Century Group Provides Strategy Update Letter from CEO

WILLIAMSVILLE, N.Y., Sept. 24, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven by next...
September 17, 2020 16:05 ET | Source: 22nd Century Group, Inc

22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors

WILLIAMSVILLE, N.Y., Sept. 17, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven by next...
August 27, 2020 11:30 ET | Source: 22nd Century Group, Inc

22nd Century Group to Present at the LD Micro 500 Virtual Conference

WILLIAMSVILLE, N.Y., Aug. 27, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based life science company driven by next...